Business Description
Prism Biolab Co Ltd
ISIN : JP3833190006
Description
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.75 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.06 | |||||
| 9-Day RSI | 42.06 | |||||
| 14-Day RSI | 39.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.95 | |||||
| Quick Ratio | 3.95 | |||||
| Cash Ratio | 3.82 | |||||
| Days Sales Outstanding | 11.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.95 | |||||
| Operating Margin % | -289.51 | |||||
| Net Margin % | -291 | |||||
| FCF Margin % | 285.1 | |||||
| ROE % | -19.43 | |||||
| ROA % | -15.64 | |||||
| ROIC % | -81.81 | |||||
| ROC (Joel Greenblatt) % | -79413.78 | |||||
| ROCE % | -19.32 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 87.27 | |||||
| PB Ratio | 4.36 | |||||
| Price-to-Tangible-Book | 4.47 | |||||
| Price-to-Free-Cash-Flow | 30.61 | |||||
| Price-to-Operating-Cash-Flow | 29.62 | |||||
| EV-to-EBIT | -17.75 | |||||
| EV-to-EBITDA | -17.75 | |||||
| EV-to-Revenue | 51.36 | |||||
| EV-to-FCF | 21.51 | |||||
| Price-to-Net-Current-Asset-Value | 4.52 | |||||
| Price-to-Net-Cash | 4.72 | |||||
| Earnings Yield (Greenblatt) % | -5.64 | |||||
| FCF Yield % | 3.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prism Biolab Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 115.482 | ||
| EPS (TTM) (円) | -9.505 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 39.04 | ||
| 14-Day ATR (円) | 14.299896 | ||
| 20-Day SMA (円) | 304.9 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (円) | 274 - 672 | ||
| Shares Outstanding (Mil) | 35.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prism Biolab Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prism Biolab Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prism Biolab Co Ltd Frequently Asked Questions
What is Prism Biolab Co Ltd(TSE:206A)'s stock price today?
The current price of TSE:206A is 円292.00. The 52 week high of TSE:206A is 円672.00 and 52 week low is 円274.00.
When is next earnings date of Prism Biolab Co Ltd(TSE:206A)?
The next earnings date of Prism Biolab Co Ltd(TSE:206A) is .
Does Prism Biolab Co Ltd(TSE:206A) pay dividends? If so, how much?
Prism Biolab Co Ltd(TSE:206A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers